AIFarm, Ltd.
Other OTCTotal Valuation
AIFarm, Ltd. carries a market capitalization of 2,079.00, placing it among publicly traded companies globally. Its enterprise value stands at -1.03M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 2,079.00 |
| Enterprise Value | -1.03M |
Share Statistics
AIFarm, Ltd. currently has 676,827.00 shares outstanding.
| Shares Outstanding | 676,827.00 |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Valuation Ratios
| PE Ratio | N/A |
| PS Ratio | N/A |
| PB Ratio | -0.10 |
| P/TBV Ratio | -0.18 |
| P/FCF Ratio | -1.02 |
| P/OCF Ratio | -1.02 |
Financial Position
AIFarm, Ltd. maintains a current ratio of 0.03, meaning it holds 0.0x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 0.03 |
| Quick Ratio | 0.03 |
| Debt / Equity | N/A |
| Debt / EBITDA | N/A |
| Interest Coverage | N/A |
Financial Efficiency
| Return on Equity (ROE) | N/A |
| Return on Assets (ROA) | -590.20 |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | N/A |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | N/A |
Stock Price Statistics
AIFarm, Ltd.'s stock has declined approximately -99.7% over the past 52 weeks. The 50-day moving average sits at 0.00, while the 200-day moving average is 0.00.
| Beta (5Y) | N/A |
| 52-Week Price Change | -99.7% |
| 50-Day Moving Average | 0.00 |
| 200-Day Moving Average | 0.00 |
| Average Volume (20 Days) | N/A |
Income Statement
EBITDA reached -487,134.00, while operating income came in at -487,134.00.
| Revenue | N/A |
| Gross Profit | N/A |
| Operating Income | -487,134.00 |
| Pretax Income | -547,097.00 |
| Net Income | -547,089.00 |
| EBITDA | -487,134.00 |
| EBIT | -487,134.00 |
| Earnings Per Share (EPS) | -1.00 |
Balance Sheet
Total book value stands at -6.17M, with working capital of -3.39M providing operational flexibility.
| Cash & Cash Equivalents | 88,274.00 |
| Total Debt | N/A |
| Net Debt | -88,274.00 |
| Equity (Book Value) | -6.17M |
| Book Value Per Share | -11.23 |
| Working Capital | -3.39M |
Cash Flow
AIFarm, Ltd. produced -590,903.00 in operating cash flow over the past twelve months.
| Operating Cash Flow | -590,903.00 |
| Capital Expenditures | N/A |
| Free Cash Flow | -590,903.00 |
| FCF Per Share | -1.08 |
Dividends & Yields
| Dividend Per Share | N/A |
| Dividend Yield | N/A |
| Payout Ratio | N/A |
| Shareholder Yield | -96.93 |
| FCF Yield | -97.78 |
Stock Splits
AIFarm, Ltd.'s most recent stock split took place on April 28, 2020 with a 100:1 split ratio.
| Last Split Date | 4/28/2020 |
| Split Ratio | 100:1 |
Scores
AIFarm, Ltd. posts an Altman Z-Score of -162.06, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | -162.06 |